Substantia Nigra (metabolism) < Substantia Nigra (pathology) < Substantia Nigra (physiology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000023 (1999)	A S Pakiam [Canada] ; C. Bergeron ; A E Lang	Diffuse Lewy body disease presenting as multiple system atrophy.
000036 (1999)	M A Bédard [Canada] ; B. Pillon ; B. Dubois ; N. Duchesne ; H. Masson ; Yves Agid [France]	Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
000084 (2000)	K A Baker [Canada] ; M. Hong ; D. Sadi ; I. Mendez	Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
000095 (2000)	F. Calon [Canada] ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
000168 (2001)	C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O Poulter	Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
000173 (2001)	G A Metz [Canada] ; T. Farr ; M. Ballermann ; I Q Whishaw	Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats.
000174 (2001)	A H Rajput [Canada]	Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
000273 (2003)	Patricia Vergara-Aragon ; Claudia L R. Gonzalez ; Ian Q. Whishaw	A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.
000305 (2003)	Stephen J. Crocker [Canada] ; Patrice D. Smith ; Vernice Jackson-Lewis ; Wiplore R. Lamba ; Shawn P. Hayley ; Erich Grimm ; Steve M. Callaghan ; Ruth S. Slack ; Edon Melloni ; Serge Przedborski ; George S. Robertson ; Hymie Anisman ; Zul Merali ; David S. Park	Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
000366 (2003)	Patrick L. Mcgeer [Canada] ; Claudia Schwab ; Andre Parent ; Doris Doudet	Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
000421 (2004)	Anthony E. Lang [Canada] ; Jose A. Obeso	Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
000433 (2004)	Donald B. Calne [Canada] ; Yoshikuni Mizuno	The neuromythology of Parkinson's Disease.
000537 (2005)	Ivar Mendez ; Rosario Sanchez-Pernaute [États-Unis] ; Oliver Cooper [États-Unis] ; Angel Vi Uela [États-Unis] ; Daniela Ferrari [États-Unis] ; Lars Björklund [États-Unis] ; Alain Dagher [Canada] ; Ole Isacson [États-Unis]	Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease
000565 (2005)	Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann ; Lori K. Smith ; Karim Fouad	The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
000662 (1991)	W G Tatton [Canada] ; C E Greenwood	Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
000694 (2006)	W Lok Au [Canada] ; J R Adams ; A. Troiano ; A J Stoessl	Neuroimaging in Parkinson's disease.
000715 (2006)	Junchao Tong [Canada] ; Oleh Hornykiewicz ; Stephen J. Kish	Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.
000744 (2007)	Anthony E. Lang [Canada]	The progression of Parkinson disease: a hypothesis.
000844 (2008)	Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer	Glial reactions in Parkinson's disease.
000A11 (1991)	A H Rajput [Canada] ; B. Rozdilsky ; A. Rajput	Accuracy of clinical diagnosis in parkinsonism--a prospective study.
000A52 (1991)	B. Lavoie [Canada] ; A. Parent ; P J Bédard	Effects of dopamine denervation on striatal peptide expression in parkinsonian monkeys.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Substantia Nigra (pathology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Substantia Nigra (pathology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Substantia Nigra (pathology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022